Bullish indicating open at $55-$60, IPO prices at $37
PARIS - Havas N.V. (EURONEXT:HAVAS) has repurchased 870,528 of its own shares between August 4 and August 8, 2025, at an average price of €1.4870 per share, according to a company statement Monday. The company, currently trading at €1.75, appears undervalued according to InvestingPro analysis, with a P/E ratio of 8.4x and an attractive dividend yield of 5.4%.
The transactions are part of the €50 million share buyback program that the global communications group announced on May 28, 2025.
Since the program’s inception, Havas has repurchased a total of 7,165,391 shares at an average price of €1.4896, representing a total consideration of approximately €10.7 million based on the reported average price.
The Paris-based company provides weekly updates on the progress of its share repurchase program every Monday on its corporate website.
Havas, founded in 1835, operates in over 100 markets worldwide with approximately 23,000 employees. The company offers integrated communications services through its "Converged" operating system, which combines expertise in creative, media, and data capabilities.
The share buyback program represents one of the company’s ongoing capital allocation strategies, as outlined in the press release statement.
In other recent news, Havas reported its first-half 2025 financial results, which were largely in line with expectations. The company’s EBITA exceeded forecasts, although its unadjusted net income fell short of projections. Havas achieved 2.6% organic growth in the second quarter, slightly surpassing analyst estimates of 2.5%. Management has decided to maintain its full-year 2025 guidance, consistent with previous announcements. In another development, Goldman Sachs initiated coverage of Havas with a Buy rating and set a price target of EUR1.90. The firm highlighted Havas’ promising risk/reward profile and potential for earnings growth. Goldman Sachs pointed to the company’s strong geographic and category exposure, including 29% of its revenue from the Health sector, as key strengths. Additionally, Havas’ net new business and solid balance sheet were noted as positive indicators.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.